U.S. PHYSICAL THERAPY INC (USPH) Forecast, Price Target & Analyst Ratings

NYSE:USPH • US90337L1089

Current stock price

76.83 USD
-1.05 (-1.35%)
At close:
76.83 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for U.S. PHYSICAL THERAPY INC (USPH).

Forecast Snapshot

Consensus Price Target

Price Target
$106.28
+ 38.34% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.58
Revenue Estimate
201.94M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.62%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$106.28
Upside
+ 38.34%
From current price of $76.83 to mean target of $106.28, Based on 13 analyst forecasts
Low
$98.98
Median
$105.06
High
$118.65

Price Target Revisions

1 Month
2.16%
3 Months
-0.92%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for USPH. The average price target is 106.28 USD. This implies a price increase of 38.34% is expected in the next year compared to the current price of 76.83.
The average price target has been revised downward by 0.92% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

USPH Current Analyst RatingUSPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

USPH Historical Analyst RatingsUSPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.62%
USPH was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about USPH.
In the previous month the buy percentage consensus was at a similar level.
USPH was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-20Barrington ResearchMaintains Outperform -> Outperform
2026-01-05Barrington ResearchMaintains Outperform -> Outperform
2025-11-24JP MorganMaintains Overweight -> Overweight
2025-10-24Barrington ResearchMaintains Outperform -> Outperform
2025-08-08Barrington ResearchMaintains Outperform -> Outperform
2025-07-01Barrington ResearchMaintains Outperform -> Outperform
2025-04-22JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-03-19JP MorganMaintains Overweight -> Overweight
2025-02-28Barrington ResearchMaintains Outperform -> Outperform
2024-12-16JMP SecuritiesInitiate Market Outperform
2024-12-16B of A SecuritiesUpgrade Neutral -> Buy
2024-12-03JP MorganMaintains Overweight -> Overweight
2024-11-21Barrington ResearchMaintains Outperform -> Outperform
2024-11-07Barrington ResearchMaintains Outperform -> Outperform
2024-10-09Barrington ResearchMaintains Outperform -> Outperform
2024-10-07B of A SecuritiesDowngrade Buy -> Neutral
2024-09-20Barrington ResearchMaintains Outperform -> Outperform
2024-08-15Barrington ResearchMaintains Outperform -> Outperform
2024-05-09Barrington ResearchMaintains Outperform -> Outperform
2024-03-13JP MorganMaintains Overweight -> Overweight
2024-03-01Barrington ResearchMaintains Outperform -> Outperform
2024-01-03Barrington ResearchMaintains Outperform -> Outperform
2023-11-17JP MorganMaintains Overweight -> Overweight
2023-11-09Barrington ResearchMaintains Outperform -> Outperform
2023-09-22JP MorganInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.58
Revenue Estimate
201.94M
Revenue Q2Q
9.88%
EPS Q2Q
20.42%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.04%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

USPH is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.58 USD and the consensus revenue estimate is 201.94M USD.
The next earnings revenue estimate has been revised downward by 0.04% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
USPH revenue by date.USPH revenue by date.
553.1M
11.74%		604.802M
9.35%		671.345M
11.00%		794.2M
18.30%		846.34M
6.57%		900.76M
6.43%		1.004B
11.46%
EBITDA
YoY % growth
USPH ebitda by date.USPH ebitda by date.
80.64M
-2.01%		85.251M
5.72%		88.667M
4.01%		96.875M
9.26%		105.91M
9.33%		117.17M
10.63%		132.12M
12.76%
EBIT
YoY % growth
USPH ebit by date.USPH ebit by date.
65.9M
-6.79%		69.556M
5.55%		69.986M
0.62%		86.535M
23.65%		91.516M
5.76%		95.519M
4.37%		N/A
Operating Margin
USPH operating margin by date.USPH operating margin by date.
11.91%11.50%10.42%10.90%10.81%10.60%N/A
EPS
YoY % growth
USPH eps by date.USPH eps by date.
2.71
-14.51%		2.56
-5.54%		2.58
0.78%		2.68
1.55%		3.11
18.55%		3.51
13.14%		3.96
12.63%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.58
20.42%		0.89
10.40%		0.76
15.39%		0.76
13.42%		0.64
11.18%		0.89
-0.76%		0.93
21.87%		0.85
11.41%
Revenue
Q2Q % growth		201.94M
9.88%		213.19M
8.03%		212.69M
7.89%		216.12M
6.61%		212.57M
5.26%		220.94M
3.64%		220.6M
3.72%		225.98M
4.56%
EBITDA
Q2Q % growth		21.711M
-15.69%		29.225M
-20.87%		26.524M
-38.38%		27.275M
8.29%		23.776M
9.51%		31.013M
6.12%		29.672M
11.87%		29.718M
8.96%
EBIT
Q2Q % growth		19.669M
-1.08%		27.125M
8.47%		23.958M
-5.26%		25.314M
18.31%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

USPH Yearly Revenue VS EstimatesUSPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
USPH Yearly EPS VS EstimatesUSPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.74%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.13%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
19.27%
EBIT Next 5 Year
17.61%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

U.S. PHYSICAL THERAPY INC / USPH Forecast FAQ

What is the average price target for U.S. PHYSICAL THERAPY INC (USPH) stock?

13 analysts have analysed USPH and the average price target is 106.28 USD. This implies a price increase of 38.34% is expected in the next year compared to the current price of 76.83.

What is the next earnings date for USPH stock?

U.S. PHYSICAL THERAPY INC (USPH) will report earnings on 2026-05-05.

What are the consensus estimates for USPH stock next earnings?

The consensus EPS estimate for the next earnings of U.S. PHYSICAL THERAPY INC (USPH) is 0.58 USD and the consensus revenue estimate is 201.94M USD.

What is the consensus rating for U.S. PHYSICAL THERAPY INC (USPH) stock?

The consensus rating for U.S. PHYSICAL THERAPY INC (USPH) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.